Join the Crohn's Disease - Acute group to help and get support from people like you.
Crohn's Disease - Acute News (Page 3)
FDA Approves Renflexis (infliximab-abda), a Biosimilar to Remicade
INCHEON, Korea – April 24, 2017 – Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Renflexis (infliximab-abda), a biosimilar referencing Rem...
Further information
Related condition support groups
Related drug support groups
prednisone, metronidazole, Humira, ciprofloxacin, hydrocortisone, betamethasone, cortisone, prednisolone, Remicade, view more... Stelara, dexamethasone, adalimumab, budesonide, ustekinumab, Cimzia